On the public citation graph
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
0 signed · 168 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/bjs.7393openalex-snapshot
Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.20486openalex-snapshot
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
inferredcites →https://doi.org/10.1002/hep.24710openalex-snapshot
Hepatocellular Carcinoma Confirmation, Treatment, and Survival in Surveillance, Epidemiology, and End Results Registries, 1992-2008
inferredcites →https://doi.org/10.1002/ijc.25516openalex-snapshot
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
inferredcites →https://doi.org/10.1007/s00535-008-2251-0openalex-snapshot
Epidemiology of hepatocellular carcinoma in Japan
inferredcites →https://doi.org/10.1016/j.jhep.2008.05.018openalex-snapshot
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey
inferredcites →https://doi.org/10.1016/j.jhep.2009.02.003openalex-snapshot
Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/s0140-6736(03)14964-1openalex-snapshot
Hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/s0168-8278(04)90256-5openalex-snapshot
256 JIS scoring system combined with 3 tumor makers (modified JIS score) is an exellent prognostic staging system for hepatocellular carcinoma (HCC): Analysis of 4525 patients with HCC
inferredcites →https://doi.org/10.1016/s1470-2045(08)70285-7openalex-snapshot
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
inferredcites →https://doi.org/10.1053/j.gastro.2006.05.021openalex-snapshot
Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients
inferredcites →https://doi.org/10.1055/s-0030-1247132openalex-snapshot
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1056/nejm199603143341104openalex-snapshot
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
inferredcites →https://doi.org/10.1056/nejmoa0708857openalex-snapshot
Sorafenib in Advanced Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1111/hepr.12542openalex-snapshot
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)
inferredcites →https://doi.org/10.1111/j.1440-1746.2009.06167.xopenalex-snapshot
Prevention of hepatocellular carcinoma in the Asia–Pacific region: Consensus statements
inferredcites →https://doi.org/10.1111/j.1872-034x.2007.00119.xopenalex-snapshot
Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan†
inferredcites →https://doi.org/10.1111/j.1872-034x.2007.00216.xopenalex-snapshot
Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
inferredcites →https://doi.org/10.1111/j.1872-034x.2010.00674.xopenalex-snapshot
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)
inferredcites →https://doi.org/10.1111/j.1872-034x.2010.00731.xopenalex-snapshot
Report of the 18th follow‐up survey of primary liver cancer in Japan
inferredcites →https://doi.org/10.1111/j.1872-034x.2011.00880.xopenalex-snapshot
Demonstration of quality of care measurement using the Japanese liver cancer registry
inferredcites →https://doi.org/10.1159/000327577openalex-snapshot
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
inferredcites →https://doi.org/10.1159/000462153openalex-snapshot
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.
inferredcites →https://doi.org/10.1159/000463378openalex-snapshot
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1177/1756283x10385964openalex-snapshot
Surveillance for hepatocellular carcinoma: in whom and how?
inferredcites →https://doi.org/10.2214/ajr.09.3308openalex-snapshot
Overall Survival After Transarterial Lipiodol Infusion Chemotherapy With or Without Embolization for Unresectable Hepatocellular Carcinoma: Propensity Score Analysis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3739823openalex-extracted
Development and Validation of Prognostic Nomograms for BCLC A Stage Hepatocellular Carcinoma Beyond Milan Criteria after Curative Resection
inferred← citeshttps://doi.org/10.1002/ags3.12451openalex-snapshot
Changes in patient background and prognosis after hepatectomy for hepatocellular carcinoma by hepatitis virus infection status: New trends in Japan
inferred← citeshttps://doi.org/10.1002/cam4.6030openalex-snapshot
Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jgh3.12819openalex-snapshot
Efficacy of rechallenge transcatheter arterial chemoembolization after lenvatinib treatment for advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jmri.29323openalex-snapshot
Editorial for “Multi‐Phase MRI ‐Based Radiomics for Predicting Histological Grade of Hepatocellular Carcinoma”
inferred← citeshttps://doi.org/10.1002/lci2.22openalex-snapshot
T‐cell mediated responses against alpha‐foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival
inferred← citeshttps://doi.org/10.1002/prp2.486openalex-snapshot
Database analysis of patients with hepatocellular carcinoma and treatment flow in early and advanced stages
inferred← citeshttps://doi.org/10.1007/978-3-030-79256-5_10openalex-snapshot
Basic Properties of Ultrasound Contrast Agents
inferred← citeshttps://doi.org/10.1007/978-3-032-15764-5_7openalex-snapshot
Enhancing Hepatocellular Carcinoma Survival Prediction Through Data Balancing and Explainable Artificial Intelligence
inferred← citeshttps://doi.org/10.1007/s00259-018-4152-7openalex-snapshot
Transarterial radioembolization in patients with hepatocellular carcinoma of intermediate B2 substage
inferred← citeshttps://doi.org/10.1007/s00535-019-01642-1openalex-snapshot
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
inferred← citeshttps://doi.org/10.1007/s00595-021-02237-1openalex-snapshot
Anatomical resection is useful for the treatment of primary solitary hepatocellular carcinoma with predicted microscopic vessel invasion and/or intrahepatic metastasis
inferred← citeshttps://doi.org/10.1007/s00595-021-02239-zopenalex-snapshot
Clinical outcome of cardiac surgery in patients with remitted or active hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1007/s10269-017-2712-2openalex-snapshot
Carcinome hépatocellulaire : nouveaux concepts, nouvelles molécules et nouvelles approches
inferred← citeshttps://doi.org/10.1007/s10396-019-01001-wopenalex-snapshot
Application of new ultrasound techniques for focal liver lesions
inferred← citeshttps://doi.org/10.1007/s10396-022-01204-8openalex-snapshot
Contrast-enhanced ultrasonography for blood flow detection in hepatocellular carcinoma during lenvatinib therapy
inferred← citeshttps://doi.org/10.1007/s10396-024-01507-yopenalex-snapshot
Enhancing deep-seated hepatocellular carcinoma detection: assessing the added value of high mechanical index setting in sonazoid-based contrast-enhanced ultrasound during post-vascular phase
inferred← citeshttps://doi.org/10.1007/s12072-017-9799-9openalex-snapshot
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
inferred← citeshttps://doi.org/10.1007/s12072-019-09937-4openalex-snapshot
Current status and perspectives for computer-aided ultrasonic diagnosis of liver lesions using deep learning technology
inferred← citeshttps://doi.org/10.1007/s12094-017-1626-1openalex-snapshot
Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s40268-023-00416-8openalex-snapshot
A Phase I Study to Investigate the Safety, Tolerability and Pharmacokinetics of Napabucasin Combined with Sorafenib in Japanese Patients with Unresectable Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-99136-0.00007-6openalex-snapshot
Artificial intelligence in liver cancer
inferred← citeshttps://doi.org/10.1016/j.canlet.2019.12.002openalex-snapshot
Immunotherapy for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.07.009openalex-snapshot
Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection
inferred← citeshttps://doi.org/10.1016/j.gene.2019.143944openalex-snapshot
LncRNA PLAC2 upregulates p53 to induce hepatocellular carcinoma cell apoptosis
inferred← citeshttps://doi.org/10.1016/j.ijsu.2018.03.033openalex-snapshot
Hepatocellular carcinoma with en bloc diaphragmatic resection: A single-center experience over 14 years
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.113662openalex-snapshot
Identification of prognostic tumor microenvironment in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors
inferred← citeshttps://doi.org/10.1016/j.pan.2022.03.017openalex-snapshot
The clinical benefits of performing staging laparoscopy for pancreatic cancer treatment
inferred← citeshttps://doi.org/10.1016/j.suronc.2021.101609openalex-snapshot
Continuous improvements in short and long-term outcomes after partial hepatectomy for hepatocellular carcinoma in the 21st century: Single institution experience with 1300 resections over 18 years
inferred← citeshttps://doi.org/10.1016/j.suronc.2021.101663openalex-snapshot
Efficacy and safety of sorafenib plus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)01200-4openalex-snapshot
Hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/s1470-2045(19)30165-2openalex-snapshot
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein
inferred← citeshttps://doi.org/10.1016/s2468-1253(18)30078-5openalex-snapshot
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial
inferred← citeshttps://doi.org/10.1038/bjc.2016.422openalex-snapshot
Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance
inferred← citeshttps://doi.org/10.1038/s41416-021-01260-wopenalex-snapshot
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
inferred← citeshttps://doi.org/10.1038/s41418-025-01536-1openalex-snapshot
The PLEKHA1-TACC2 fusion gene drives tumorigenesis via vascular mimicry formation in esophageal squamous-cell carcinoma
inferred← citeshttps://doi.org/10.1038/s41598-019-44022-8openalex-snapshot
Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1056/nejmoa0708857openalex-snapshot
Sorafenib in Advanced Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1080/09553002.2022.2094020openalex-snapshot
Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses
inferred← citeshttps://doi.org/10.1093/bjs/znaa109openalex-snapshot
Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study
inferred← citeshttps://doi.org/10.1097/jcma.0000000000000001openalex-snapshot
Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy
inferred← citeshttps://doi.org/10.1097/md.0000000000020745openalex-snapshot
Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/md.0000000000046799openalex-snapshot
Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/meg.0000000000001193openalex-snapshot
Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000684openalex-snapshot
Hepatocellular Carcinoma—Southeast Asia Updates
inferred← citeshttps://doi.org/10.1111/hepr.13438openalex-snapshot
Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan
inferred← citeshttps://doi.org/10.1111/hepr.13612openalex-snapshot
Report of the 21st Nationwide Follow‐up Survey of Primary Liver Cancer in Japan (2010–2011)
inferred← citeshttps://doi.org/10.1111/hepr.13675openalex-snapshot
Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)
inferred← citeshttps://doi.org/10.1111/hepr.13953openalex-snapshot
Report of the 23rd nationwide follow‐up survey of primary liver cancer in Japan (2014–2015)
inferred← citeshttps://doi.org/10.1111/hepr.70070openalex-snapshot
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early‐Stage Viral Disease
inferred← citeshttps://doi.org/10.1111/jgh.15413openalex-snapshot
Artificial intelligence in the diagnosis and management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1111/liv.15251openalex-snapshot
Changing epidemiology of hepatocellular carcinoma in Asia
inferred← citeshttps://doi.org/10.1159/000462153openalex-snapshot
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.
inferred← citeshttps://doi.org/10.1159/000479984openalex-snapshot
Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function
inferred← citeshttps://doi.org/10.1159/000480137openalex-snapshot
New Era of the Management of Liver Diseases and Liver Cancer: State-of-the-Art Progress in 2017
inferred← citeshttps://doi.org/10.1159/000480140openalex-snapshot
Diagnosis of Fibrosis and Activity by a Combined Use of Strain and Shear Wave Imaging in Patients with Liver Disease
inferred← citeshttps://doi.org/10.1159/000480143openalex-snapshot
Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C
inferred← citeshttps://doi.org/10.1159/000480145openalex-snapshot
Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2
inferred← citeshttps://doi.org/10.1159/000480147openalex-snapshot
Hepatocarcinogenesis Is Associated with Serum Albumin Levels after Sustained Virological Responses with Interferon-Based Therapy in Patients with Hepatitis C
inferred← citeshttps://doi.org/10.1159/000480148openalex-snapshot
Unique Characteristics Associated with Sustained Liver Damage in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals
inferred← citeshttps://doi.org/10.1159/000480183openalex-snapshot
Hepatocellular Carcinoma after Achievement of Sustained Viral Response with Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus Infection
inferred← citeshttps://doi.org/10.1159/000480186openalex-snapshot
Impact of Tumor Factors on Survival in Patients with Hepatocellular Carcinoma Classified Based on Kinki Criteria Stage B2
inferred← citeshttps://doi.org/10.1159/000480208openalex-snapshot
Time to Transcatheter Arterial Chemoembolization Refractoriness in Patients with Hepatocellular Carcinoma in Kinki Criteria Stages B1 and B2
inferred← citeshttps://doi.org/10.1159/000480255openalex-snapshot
Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study
inferred← citeshttps://doi.org/10.1159/000480256openalex-snapshot
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis
inferred← citeshttps://doi.org/10.1159/000480257openalex-snapshot
Sorafenib-Regorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma: A Single-Institute Experience
inferred← citeshttps://doi.org/10.1159/000480258openalex-snapshot
Role of Immune Checkpoint Blockade in the Treatment for Human Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000481222openalex-snapshot
New Paradigm in Gastrointestinal Cancer Treatment
inferred← citeshttps://doi.org/10.1159/000481236openalex-snapshot
Primary Hepatic Adenosquamous Carcinoma Associated with Primary Sclerosing Cholangitis
inferred← citeshttps://doi.org/10.1159/000481242openalex-snapshot
Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases
inferred← citeshttps://doi.org/10.1159/000481244openalex-snapshot
Systemic Therapy for Hepatocellular Carcinoma: 2017 Update
inferred← citeshttps://doi.org/10.1159/000481245openalex-snapshot
Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update
inferred← citeshttps://doi.org/10.1159/000481246openalex-snapshot
Oncogenic Signal and Tumor Microenvironment in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000484619openalex-snapshot
Management of Hepatocellular Carcinoma in Japan as a World-Leading Model
inferred← citeshttps://doi.org/10.1159/000486902openalex-snapshot
Long-Term Prognostic Factors after Hepatic Resection for Hepatitis C Virus-Related Hepatocellular Carcinoma, with a Special Reference to Viral Status
inferred← citeshttps://doi.org/10.1159/000487407openalex-snapshot
The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade
inferred← citeshttps://doi.org/10.1159/000496225openalex-snapshot
Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation
inferred← citeshttps://doi.org/10.1159/000503032openalex-snapshot
Objective Response by mRECIST Is an Independent Prognostic Factor for Overall Survival in Hepatocellular Carcinoma Treated with Sorafenib in the SILIUS Trial
inferred← citeshttps://doi.org/10.1159/000504193openalex-snapshot
Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiology, and End-Results Database
inferred← citeshttps://doi.org/10.1159/000505370openalex-snapshot
Management of Hepatocellular Carcinoma in Japan: Current Trends
inferred← citeshttps://doi.org/10.1159/000506135openalex-snapshot
Human Telomerase Reverse Transcriptase Gene Promoter Mutation in Serum of Patients with Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000507022openalex-snapshot
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1159/000514174openalex-snapshot
Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update
inferred← citeshttps://doi.org/10.1159/000516491openalex-snapshot
Surveillance, Diagnosis, and Treatment Outcomes of Hepatocellular Carcinoma in Japan: 2021 Update
inferred← citeshttps://doi.org/10.1159/000533650openalex-snapshot
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1186/s12885-021-08858-6openalex-snapshot
Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: a multicenter retrospective study
inferred← citeshttps://doi.org/10.1186/s12885-023-11693-6openalex-snapshot
Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients
inferred← citeshttps://doi.org/10.1186/s12885-024-12676-xopenalex-snapshot
Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
inferred← citeshttps://doi.org/10.1186/s13027-020-00300-zopenalex-snapshot
Tumor aggression among hepatitis-C related hepatocellular carcinoma patients: an observational study regarding the impact of anti-HCV therapy
inferred← citeshttps://doi.org/10.1200/jco-25-01796openalex-snapshot
Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial
inferred← citeshttps://doi.org/10.1245/s10434-019-07911-wopenalex-snapshot
The Achievement of a Sustained Virological Response Either Before or After Hepatectomy Improves the Prognosis of Patients with Primary Hepatitis C Virus-Related Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1245/s10434-023-14462-8openalex-snapshot
Laparoscopically Limited Anatomic Liver Resections: A Single-Center Analysis for Oncologic Outcomes of the Conceptual Procedure
inferred← citeshttps://doi.org/10.17179/excli2019-1842openalex-snapshot
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.
inferred← citeshttps://doi.org/10.17998/jlc.2022.11.07openalex-snapshot
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.20517/2394-5079.2018.93openalex-snapshot
Simple screening method for the diagnosis of nonB-nonC hepatocellular carcinoma
inferred← citeshttps://doi.org/10.20517/2394-5079.2020.129openalex-snapshot
Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection
inferred← citeshttps://doi.org/10.20944/preprints201907.0075.v1openalex-snapshot
Objective Response by mRECIST is an Independent Prognostic Factor for overall Survival in Hepatocellular Carcinoma in SILIUS Trial
inferred← citeshttps://doi.org/10.21037/ace.2019.07.01openalex-snapshot
Survival trends for primary liver cancer, 1995–2009: analysis of individual data for 578,740 patients from 187 population-based registries in 36 countries (CONCORD-2)
inferred← citeshttps://doi.org/10.21037/jgo-21-356openalex-snapshot
Stereotactic body radiation therapy versus radiofrequency ablation for single small hepatocellular carcinoma: a propensity-score matching analysis of their impact on liver function and clinical outcomes
inferred← citeshttps://doi.org/10.21203/rs.3.rs-228801/v1openalex-snapshot
Stereotactic Body Radiation Therapy vs. Radiofrequency Ablation for Single Small Hepatocellular Carcinoma: A Propensity-score Matching Analysis of Their Impact on Liver Function and Clinical Outcomes
inferred← citeshttps://doi.org/10.21203/rs.3.rs-3012265/v1openalex-snapshot
Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
inferred← citeshttps://doi.org/10.2147/jhc.s390858openalex-snapshot
Development and Validation of Prognostic Nomograms for Hepatocellular Carcinoma After Hepatectomy Based on Inflammatory Markers
inferred← citeshttps://doi.org/10.2147/jhc.s439001openalex-snapshot
Atezolizumab Plus Bevacizumab Combined with Transarterial Embolization Plus Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma with a Diameter >8 Cm: A Retrospective Study
inferred← citeshttps://doi.org/10.21873/anticanres.13333openalex-snapshot
Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by Etiology
inferred← citeshttps://doi.org/10.21873/anticanres.14509openalex-snapshot
Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor Signaling
inferred← citeshttps://doi.org/10.21873/invivo.12270openalex-snapshot
The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis
inferred← citeshttps://doi.org/10.2739/kurumemedj.ms6834010openalex-snapshot
Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial
inferred← citeshttps://doi.org/10.2957/kanzo.59.587openalex-snapshot
Systemic Therapy for Hepatocellular Carcinoma: Recent Advances
inferred← citeshttps://doi.org/10.2957/kanzo.61.692openalex-snapshot
Clinical implications of estimating the volume of new lesions in evaluating the effects of TACE for hepatocellular carcinoma
inferred← citeshttps://doi.org/10.31557/apjcp.2020.21.10.2903openalex-snapshot
New Hepatic Resection Criteria for Intermediate-Stage Hepatocellular Carcinoma Can Improve Long-Term Survival: A Retrospective, Multicenter Collaborative Study
inferred← citeshttps://doi.org/10.3348/jksr.2022.0144openalex-snapshot
CT/MRI Liver Imaging Reporting and Data System (LI-RADS): Standardization, Evidence, and Future Direction
inferred← citeshttps://doi.org/10.3348/kjr.2018.0450openalex-snapshot
Emerging Role of Hepatobiliary Magnetic Resonance Contrast Media and Contrast-Enhanced Ultrasound for Noninvasive Diagnosis of Hepatocellular Carcinoma: Emphasis on Recent Updates in Major Guidelines
inferred← citeshttps://doi.org/10.3348/kjr.2019.0140openalex-snapshot
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3348/kjr.2022.0822openalex-snapshot
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3350/cmh.2018.0090openalex-snapshot
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
inferred← citeshttps://doi.org/10.3350/cmh.2022.0294openalex-snapshot
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3389/fgene.2022.918983openalex-snapshot
N7-Methylguanosine Genes Related Prognostic Biomarker in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers11070952openalex-snapshot
Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
inferred← citeshttps://doi.org/10.3390/cancers12103048openalex-snapshot
Exploratory Analysis of Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma Who Have Failed Prior PD−1/PD-L1 Checkpoint Blockade
inferred← citeshttps://doi.org/10.3390/cancers13010160openalex-snapshot
Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study
inferred← citeshttps://doi.org/10.3390/medicina58020259openalex-snapshot
The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/nu12041076openalex-snapshot
Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study
inferred← citeshttps://doi.org/10.36829/63cts.v4i1.251openalex-snapshot
Estado actual de la epidemiología, diagnóstico, tratamiento y control de la hepatitis C
inferred← citeshttps://doi.org/10.3748/wjg.v26.i13.1463openalex-snapshot
Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma
inferred← citeshttps://doi.org/10.3748/wjg.v28.i43.6090openalex-snapshot
Current status of minimally invasive liver surgery for cancers
inferred← citeshttps://doi.org/10.4103/2347-5625.204497openalex-snapshot
Hepatocellular carcinoma: Implications for Asia-Pacific Oncology Nurses
inferred← citeshttps://doi.org/10.4103/ejim.ejim_110_18openalex-snapshot
Prognostic value of interleukin-10 and tumor necrosis factor-α polymorphisms in patients with hepatocellular carcinoma treated with transarterial chemoembolization
inferred← citeshttps://doi.org/10.4143/crt.2018.477openalex-snapshot
Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
inferred← citeshttps://doi.org/10.4254/wjh.v9.i36.1322openalex-snapshot
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma
inferred← citeshttps://doi.org/10.5005/jp-journals-10018-1300openalex-snapshot
Treatment by Transarterial Chemoembolization and Sorafenib for Hepatocellular Carcinoma vs Advanced Hepatocellular Carcinoma in Bangladesh: A Real-life Situation
inferred← citeshttps://doi.org/10.5009/gnl19024openalex-snapshot
2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.53350/pjmhs2023172212openalex-snapshot
Diagnostic Accuracy of Doppler Scan of Portal Vein to Determine Early Cirrhosis of Hepatitis-C Patients in Gujranwala Population
inferred← citeshttps://doi.org/10.5812/ijcm-172363openalex-snapshot
Hepatocellular Carcinoma Survival in Iran (2011 - 2017): A National Registry-Based Report
inferred← citeshttps://doi.org/10.6002/ect.tond16.l2openalex-snapshot
New Developments in Orthotopic Liver Transplant for Hepatocellular Carcinoma.
inferred← citeshttps://doi.org/10.6084/m9.figshare.24751362openalex-snapshot
Additional file 1 of Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients
inferred← citeshttps://doi.org/10.6084/m9.figshare.26391686openalex-snapshot
Additional file 1 of Urinary microRNA-210-3p as a novel and non-invasive biomarker for the detection of pancreatic cancer, including intraductal papillary mucinous carcinoma
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.